Recent discoveries on the function and plasticity of central dopamine pathways;Découvertes récentes sur la fonction et la plasticité des voies dopaminergiques du cerveau

Medecine/Sciences

Volumn 26, Issue 2, 2010, Pages 165-170

  Thibault, Dominic ^a   Kortleven, Christian ^a   Fasano, Caroline ^a   Dal Bo, Gregory ^a   Trudeau, Louis Éric ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77749307316     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2010262165     Document Type: Review

References (32)

1. Beaulieu JM, Sotnikova TD, Marion S, et al. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005;122:261-73.
2. Deng YP, Lei WL, Reiner A. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat 2006;32:101-16.
3. Rashid AJ, So CH, Kong MM, et al. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 2007;104:654-9.
4. Fuxe K, Ferre S, Genedani S, et al. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav 2007;92:210-7.
5. Azdad K, Gall D, Woods AS, et al. Dopamine D2 and adenosine A2A receptors regulate NMDA- mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization. Neuropsychopharmacology 2009;34:972-86.
6. Baragli A, Alturaihi H, Watt HL, et al. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis. Cell Signal 2007;19:2304-16.
7. Juhasz JR, Hasbi A, Rashid AJ, et al. Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells. Eur J Pharmacol 2008;581:235-43.
8. Metaye T, Perdrisot R, Kraimps JL. GRKs and arrestins: the therapeutic pathway? Med Sci (Paris) 2006;22:537-43.
9. Namkung Y, Sibley DR. Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J Biol Chem 2004;279:49533-41.
10. St-Gelais F, Jomphe C, Trudeau LE. The role of neurotensin in central nervous system pathophysiology: what is the evidence? J Psychiatry Neurosci 2006;31:229-45.
11. Jomphe C, Lemelin PL, Okano H, et al. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons. Eur J Neurosci 2006;24:2789-800.
12. Parish CL, Stanic D, Drago J, et al. Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size. Eur J Neurosci 2002;16:787-94.
13. Fasano C, Poirier A, DesGroseillers L, Trudeau LE. Chronic activation of the D2 dopamine autoreceptor inhibits synaptogenesis in mesencephalic dopaminergic neurons in vitro. Eur J Neurosci 2008;28:1480-90.
14. Hill JJ, Hashimoto T, Lewis DA. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2006;11:557-66.
15. Day M, Wang Z, Ding J, et al. Selective elimination of gtutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006;9:251-9.
16. Li Y, Kolb B, Robinson TE. The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudateputamen. Neuropsychopharmacology 2003;28:1082-5.
17. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993;18:247-91.
18. Bonci A, Malenka RC. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J Neurosci 1999;19:3723-30.
19. Ungless MA, Whistler JL, Malenka RC, Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001;411:583-7.
20. Saal D, Dong Y, Bonci A, Malenka RC. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003;37:577-82.
21. Liu QS, Pu L, Poo MM. Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 2005;437:1027-31.
22. Luu P, Malenka RC. Spike timing-dependent long-term potentiation in ventral tegmental area dopamine cells requires PKC. J Neurophysiol 2008;100:533-8.
23. Argilli E, Sibley DR, Malenka RC, et al. Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J Neurosci 2008;28:9092-100.
24. Trudeau LE. Glutamate co-transmission as an emerging concept in monoamine neuron function. J Psychiatry Neurosci 2004;29:296-310.
25. Kaneko T, Akiyama H, Nagatsu I, Mizuno N. Immunohistochemical demonstration of glutaminase in catecholaminergic and serotoninergic neurons of rat brain. Brain Res 1990;507:151-4.
26. Sulzer D, Joyce MP, Lin L, et al. Dopamine neurons make glutamatergic synapses in vitro. J Neurosci 1998;18:4588-602.
27. Takamori S, Rhee JS, Rosenmund C, Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 2000;407:189-94.
28. Dal Bo G, St-Gelais F, Danik M, et al. Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine. J Neurochem 2004;88:1398-405.
29. Kawano M, Kawasaki A, Sakata-Haga H, et al. Particular subpopulations of midbrain and hypothalamic dopamine neurons express vesicular glutamate transporter 2 in the rat brain. J Comp Neurol 2006;498:581-92.
30. Mendez JA, Bourque MJ, Dal Bo G, et al. Developmental and targetdependent regulation of vesicular glutamate transporter expression by dopamine neurons. J Neurosci 2008;28:6309-18.
31. Descarries L, Watkins KC, Garcia S, Bosler O, Doucet G. Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis. J Comp Neurol 1996;375:167-86.
32. Dal Bo G, Bérubé-Carrière N, Mendez JA, et al. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. Neuroscience 2008;156:59-70.